comparemela.com

Latest Breaking News On - கேம்பிரிட்ஜ் மாசசூசெட்ஸ் - Page 15 : comparemela.com

Messenger RNA in a bottle

12/18/2020 9:20:06 AM GMT The big pharmaceutical companies have always tended to generate a somewhat mixed response when discussed in the wider context of stock picking. Usually viewed through the lens of being defensive and boring, their PR in recent years hasn’t been particularly positive, with accusations of price gouging as far back as the 2016 Presidential election campaign when Democrat nominee Hillary Clinton pledged to rein in the sector after an outcry over the CEO of Mylan who gradually hiked prices on EpiPen’s to the tune of 461%, from $56.64 to $317.82, since acquiring the rights in 2007. Mylan also hiked prices on a range of other products and it is a form of behaviour that is quite common on various drugs, where there is little or no alternative.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.